Share

November 2018; 5 (6) ArticleOpen Access

The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD

Amal P.R. Samaraweera, Yasser Falah, Alain Pitiot, Robert A. Dineen, Paul S. Morgan, Nikos Evangelou
First published September 26, 2018, DOI: https://doi.org/10.1212/NXI.0000000000000496
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
844

Share

Article Information

vol. 5 no. 6 e496
DOI: 
https://doi.org/10.1212/NXI.0000000000000496
PubMed: 
30345329
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received May 16, 2018
  • Accepted in final form June 28, 2018
  • First Published September 26, 2018.
Copyright & Usage: 
Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Disclosures

    1. Amal P.R. Samaraweera, PhD,
    2. Yasser Falah, MRCP,
    3. Alain Pitiot, PhD,
    4. Robert A. Dineen, PhD,
    5. Paul S. Morgan, PhD and
    6. Nikos Evangelou, DPhil
  1. Amal P.R. Samaraweera, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Biogen-Idec support for meeting and conference attendance. (2) Teva support for meeting and conference attendance. (3) Novartis support for meeting attendance, travel and speaker honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Yasser Falah, MRCP,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Alain Pitiot, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Ilixa Ltd., co-director

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Robert A. Dineen, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Paul S. Morgan, PhD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Nikos Evangelou, DPhil
    7. Scientific Advisory Boards:

    1. Compensation received for serving at advisory boards for Novartis, Biogen-Idec,Genzyme

    Gifts:

    1. Travel assistance to attend neurology conferences received by Novartis,Biogen, Teva

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. PCORI , co PI, Determining the Effectiveness of Early Intensive versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis (DELIVER-MS), Sept 2017

    Research Support, Academic Entities:

    1. Medical Research council: Explaining cognitive impairment in multiple sclerosis through integrated structural and functional networks, CiC MRC, July 2017-18, 97,316

    Research Support, Foundations and Societies:

    1. Intervention to support individuals around the point of Multiple Sclerosis diagnosis MS society, January 2017-2020

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Clinical Neuroscience (A.P.R.S., Y.F., R.A.D., N.E.), University of Nottingham; Laboratory of Image & Data Analysis (A.P.), Ilixa Ltd; National Institute of Health Research (R.A.D.), Nottingham Biomedical Research Centre; and Department of Medical Physics (P.S.M.), Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  1. Correspondence
    Dr. Samaraweera amal.samaraweera{at}doctors.org.uk
View Full Text

Article usage

Article usage: September 2018 to May 2023

AbstractFullPdfSource
Sep 2018016013Highwire
Oct 20180115893Highwire
Nov 2018035882Highwire
Dec 2018015438Highwire
Jan 2019311913Highwire
Feb 20196738Highwire
Mar 2019324617Highwire
Apr 2019818724Highwire
May 2019517814Highwire
Jun 2019311015Highwire
Jul 2019521917Highwire
Aug 2019439513Highwire
Sep 2019129816Highwire
Oct 201933338Highwire
Nov 2019224613Highwire
Dec 201931356Highwire
Jan 20200556Highwire
Feb 20202497Highwire
Mar 202034410Highwire
Apr 20203514Highwire
May 20205679Highwire
Jun 202016011Highwire
Jul 20208686Highwire
Aug 20200787Highwire
Sep 202055312Highwire
Oct 20203687Highwire
Nov 202006317Highwire
Dec 20203519Highwire
Jan 202133610Highwire
Feb 20210298Highwire
Mar 202115810Highwire
Apr 202154417Highwire
May 20213399Highwire
Jun 20212505Highwire
Jul 202125521Highwire
Aug 202135113Highwire
Sep 202133715Highwire
Oct 202136719Highwire
Nov 202166216Highwire
Dec 20214738Highwire
Jan 2022312788Highwire
Feb 202211129Highwire
Mar 2022147218Highwire
Apr 20229426Highwire
May 202268218Highwire
Jun 20225437Highwire
Jul 20221406Highwire
Aug 20225478Highwire
Sep 202235513Highwire
Oct 202256619Highwire
Nov 202277322Highwire
Dec 20225478Highwire
Jan 202356512Highwire
Feb 202344410Highwire
Mar 20230267Highwire
Apr 202332414Highwire
May 202335513Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles